Pantoprazol Alter Genéricos (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway to manage several acid‑related disorders.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the esophageal lining.
• Erosive esophagitis: accelerates ulcer healing and prevents recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding irreversibly to this pump, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea: occasional and transient.
• Abdominal pain: mild discomfort.
• Flatulence: increased intestinal gas.
• Constipation: infrequent.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): requires immediate medical attention.
• Clostridioides difficile infection: may present with persistent diarrhea.
• Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia.
• Bone fractures: associated with long‑term use.
• Liver enzyme elevation: indicates possible hepatic involvement.
• Acute interstitial nephritis: rare kidney inflammation.

Before initiating therapy with Pantoprazol Alter Genéricos, consider the following precautions:

• Assess renal function: dose adjustment may be required in severe impairment.
• Evaluate hepatic status: use with caution in patients with liver disease.
• Monitor long‑term use: prolonged therapy may increase fracture risk.
• Review concomitant medications: potential for reduced absorption of drugs requiring acidic pH.
• Pregnancy and lactation: weigh benefits against potential risks.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole may interact with several medicines, altering their effectiveness or safety profile.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH.
• HIV protease inhibitors (atazanavir, nelfinavir): decreased plasma concentrations.
• Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR; monitor coagulation.
• Methotrexate: reduced renal clearance may raise serum levels.
• Digoxin: enhanced absorption may lead to toxicity.
• Oral contraceptives: possible decrease in efficacy.
• Iron supplements: impaired absorption; consider timing separation.